Indefinite Delivery Contract SPE2DX15D9207

This Indefinite Delivery Contract (IDC) was awarded by the Defense Logistics Agency (DLA) to the woman-owned small business DMS Pharmaceutical Group Inc. The single-award IDC, valued at up to $499,999,999, enables the DLA to issue firm fixed-price delivery orders for a wide range of pharmaceutical products to support the medical supply needs of military health facilities worldwide. The contract covers an extensive portfolio of branded and generic prescription drugs, over-the-counter medications, biologics, and medical consumables across various product categories such as injections, tablets, creams, auto-injectors, and specialty medications.

The task orders issued under this IDC demonstrate DMS Pharmaceutical Group's capability to provide the DLA with a diverse array of critical pharmaceutical items, including cancer treatments, contraceptives, anesthetics, vaccines, and opioid reversal agents. These delivery orders, which do not utilize any set-asides, are awarded on a firm fixed-price basis and designate the contractor's Park Ridge, Illinois facility as the place of performance. The IDC has an ultimate completion date of December 31, 2025, allowing the DLA to leverage DMS Pharmaceutical Group's status as a woman-owned small business to fulfill its ongoing pharmaceutical requirements for military healthcare facilities.